JP6130142B2 - Topical skin preparation - Google Patents
Topical skin preparation Download PDFInfo
- Publication number
- JP6130142B2 JP6130142B2 JP2012287628A JP2012287628A JP6130142B2 JP 6130142 B2 JP6130142 B2 JP 6130142B2 JP 2012287628 A JP2012287628 A JP 2012287628A JP 2012287628 A JP2012287628 A JP 2012287628A JP 6130142 B2 JP6130142 B2 JP 6130142B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- salt
- mass
- copolymer
- acrylamido
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims description 44
- 230000000699 topical effect Effects 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 claims description 37
- 150000003839 salts Chemical class 0.000 claims description 35
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 31
- 229920001577 copolymer Polymers 0.000 claims description 31
- 229920000536 2-Acrylamido-2-methylpropane sulfonic acid Polymers 0.000 claims description 26
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 19
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 15
- 150000005690 diesters Chemical class 0.000 claims description 15
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 14
- 229930195729 fatty acid Natural products 0.000 claims description 14
- 239000000194 fatty acid Substances 0.000 claims description 14
- 150000004665 fatty acids Chemical class 0.000 claims description 14
- 239000010696 ester oil Substances 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 10
- 235000001014 amino acid Nutrition 0.000 claims description 9
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 8
- WHNPOQXWAMXPTA-UHFFFAOYSA-N 3-methylbut-2-enamide Chemical compound CC(C)=CC(N)=O WHNPOQXWAMXPTA-UHFFFAOYSA-N 0.000 claims description 7
- 229920001519 homopolymer Polymers 0.000 claims description 7
- 229940047670 sodium acrylate Drugs 0.000 claims description 7
- 150000001298 alcohols Chemical class 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 6
- 229920006037 cross link polymer Polymers 0.000 claims description 6
- 229920002401 polyacrylamide Polymers 0.000 claims description 6
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 claims description 6
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 claims description 5
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 5
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 5
- 235000013922 glutamic acid Nutrition 0.000 claims description 5
- 239000004220 glutamic acid Substances 0.000 claims description 5
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 4
- 239000004471 Glycine Substances 0.000 claims description 4
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 4
- 235000004279 alanine Nutrition 0.000 claims description 4
- 235000003704 aspartic acid Nutrition 0.000 claims description 4
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 4
- 239000004475 Arginine Substances 0.000 claims description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 3
- 239000004472 Lysine Substances 0.000 claims description 3
- GDFAOVXKHJXLEI-VKHMYHEASA-N N-methyl-L-alanine Chemical compound C[NH2+][C@@H](C)C([O-])=O GDFAOVXKHJXLEI-VKHMYHEASA-N 0.000 claims description 3
- 108010077895 Sarcosine Proteins 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 3
- 239000004473 Threonine Substances 0.000 claims description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 3
- 229940043230 sarcosine Drugs 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000000470 constituent Substances 0.000 claims description 2
- ZQXSMRAEXCEDJD-UHFFFAOYSA-N n-ethenylformamide Chemical compound C=CNC=O ZQXSMRAEXCEDJD-UHFFFAOYSA-N 0.000 claims description 2
- 239000004584 polyacrylic acid Substances 0.000 claims description 2
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 230000003020 moisturizing effect Effects 0.000 description 9
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 7
- -1 aralkyl alcohol Chemical compound 0.000 description 7
- 239000002537 cosmetic Substances 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 7
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 6
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 6
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 6
- 229920006395 saturated elastomer Polymers 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 230000004313 glare Effects 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 239000002585 base Substances 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 3
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 3
- 229940082500 cetostearyl alcohol Drugs 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 229960000735 docosanol Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 3
- 229960002446 octanoic acid Drugs 0.000 description 3
- 229960004063 propylene glycol Drugs 0.000 description 3
- 229940012831 stearyl alcohol Drugs 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 3
- 229920003169 water-soluble polymer Polymers 0.000 description 3
- DZSVIVLGBJKQAP-UHFFFAOYSA-N 1-(2-methyl-5-propan-2-ylcyclohex-2-en-1-yl)propan-1-one Chemical compound CCC(=O)C1CC(C(C)C)CC=C1C DZSVIVLGBJKQAP-UHFFFAOYSA-N 0.000 description 2
- UMHYVXGZRGOICM-AUYXYSRISA-N 2-[(z)-octadec-9-enoyl]oxypropyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC\C=C/CCCCCCCC UMHYVXGZRGOICM-AUYXYSRISA-N 0.000 description 2
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 2
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 229940031569 diisopropyl sebacate Drugs 0.000 description 2
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 150000002169 ethanolamines Chemical class 0.000 description 2
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 2
- 229940100554 isononyl isononanoate Drugs 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229940043348 myristyl alcohol Drugs 0.000 description 2
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 2
- 239000007764 o/w emulsion Substances 0.000 description 2
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229940010310 propylene glycol dioleate Drugs 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 1
- OUZOBPPZPCBJAR-UHFFFAOYSA-N 14-methylpentadecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C OUZOBPPZPCBJAR-UHFFFAOYSA-N 0.000 description 1
- YICVJSOYNBZJAK-UHFFFAOYSA-N 14-methylpentadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C YICVJSOYNBZJAK-UHFFFAOYSA-N 0.000 description 1
- BJRXGOFKVBOFCO-UHFFFAOYSA-N 2-hydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(C)O BJRXGOFKVBOFCO-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- IRLPACMLTUPBCL-KQYNXXCUSA-N 5'-adenylyl sulfate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OS(O)(=O)=O)[C@@H](O)[C@H]1O IRLPACMLTUPBCL-KQYNXXCUSA-N 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- WPKYZIPODULRBM-UHFFFAOYSA-N azane;prop-2-enoic acid Chemical compound N.OC(=O)C=C WPKYZIPODULRBM-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- DHAZIUXMHRHVMP-UHFFFAOYSA-N butyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCC DHAZIUXMHRHVMP-UHFFFAOYSA-N 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 239000008300 cosmetic paste Substances 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- BOUIEBMBWBCUPB-UHFFFAOYSA-N decyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCC BOUIEBMBWBCUPB-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 1
- 229940031016 ethyl linoleate Drugs 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229940078568 isocetyl myristate Drugs 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- XEIOPEQGDSYOIH-MURFETPASA-N propan-2-yl (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC(C)C XEIOPEQGDSYOIH-MURFETPASA-N 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は、マッサージ用リーブオン皮膚外用剤に関するものである。 The present invention relates to a leave-on skin external preparation for massage.
血行促進効果およびリフトアップ効果を目的として、古くからマッサージによる美容が行われてきた。一般的に、マッサージ効果を主たる目的としたマッサージ化粧料があり、剤型としては水系ベース、油系ベースとに大別できる。例えば、油系ベースとしては、オイルを多量に含んでおり、使用されるオイルとしては、スクワラン等の炭化水素系オイル、オリーブ油等のトリグリセライド系オイルやエステル系オイルなど、液状から半固形状のものが知られている(例えば、特許文献1)。一方、水系ベースとしては、種々の水溶性高分子を配合することでマッサージを可能としており、水性ゲルタイプのマッサージ化粧料も使用されている(例えば、特許文献2参照)。 For the purpose of blood circulation promotion effect and lift-up effect, beauty treatment by massage has been performed for a long time. In general, there are massage cosmetics mainly intended for a massage effect, and the dosage forms can be broadly classified into water bases and oil bases. For example, the oil-based base contains a large amount of oil, and the oil used is liquid to semi-solid, such as hydrocarbon oil such as squalane, triglyceride oil such as olive oil, and ester oil. Is known (for example, Patent Document 1). On the other hand, as an aqueous base, massage is possible by blending various water-soluble polymers, and aqueous gel type massage cosmetics are also used (for example, see Patent Document 2).
特許文献1の技術では、多量に含有したオイル分による使用感触の重さや、マッサージ後に皮膚に残留する油分によるべたつき、ぎらつき感や閉塞感が残るなど、みずみずしさがなく、使用感に課題があった。一方、水系ベースのマッサージ化粧料である特許文献2の技術では、水性ゲルとして汎用性の高いカルボキシビニルポリマーなどの水溶性高分子を利用する技術であるが、マッサージ性を求めると、水溶性高分子を高配合する必要が出てくるため、ヨレが生じてしまうという課題があった。特にリーブオンタイプのマッサージ化粧料では、これらの課題が顕著に感じられ、その改善が求められていた。
従って、本発明の課題は、皮膚上で伸びが良く、マッサージし易く、べたつきがなく、かつヨレを生じないマッサージ用リーブオン皮膚外用剤を提供することにある。
With the technology of Patent Document 1, there is no freshness and there is a problem with the feeling of use, such as the weight of the feeling of use due to the oil contained in a large amount, the stickiness due to the oil remaining on the skin after massage, the feeling of glare and the feeling of obstruction remain. there were. On the other hand, the technique of Patent Document 2 that is a water-based massage cosmetic is a technique that uses a water-soluble polymer such as carboxyvinyl polymer having high versatility as an aqueous gel. Since it is necessary to blend the molecules at a high level, there is a problem that twisting occurs. In particular, in leave-on type massage cosmetics, these problems were felt remarkably, and improvements were required.
Accordingly, an object of the present invention is to provide a leave-on skin external preparation for massage that has good elongation on the skin, is easy to massage, does not become sticky, and does not cause twisting.
そこで、本発明者は、前記課題を解決すべく種々検討した結果、低粘度の液状エステル油と、直鎖の高級アルコールと、N−アシルアミノ酸塩と、アクリルアミド系の水溶性高分子とを組み合わせて配合することにより、皮膚上で伸びが良くてマッサージし易く、べたつきがなく、ぎらつきやヨレを生じず、さらに保湿感、浸透感に優れ、塗布後にメイクアップも可能なマッサージ用リーブオン皮膚外用剤が得られることを見出し、本発明を完成した。 Therefore, as a result of various studies to solve the above problems, the present inventor has combined a low-viscosity liquid ester oil, a linear higher alcohol, an N-acylamino acid salt, and an acrylamide-based water-soluble polymer. When blended, it is easy to massage on the skin, is not sticky, does not cause glare and kinks, has excellent moisturizing and penetrating feeling, and can be applied after application. The present invention was completed by finding that an agent can be obtained.
すなわち、本発明は、下記成分(A)〜(D)を含有することを特徴とするマッサージ用リーブオン皮膚外用剤を提供するものである。
(A)25℃における粘度が25mPa・s以下の液状エステル油
(B)直鎖の高級アルコール
(C)N−アシルアミノ酸又はその塩
(D)2−アクリルアミド−2−メチルプロパンスルホン酸又はその塩、及びアクリルアミドから選ばれる1種又は2種以上を構成単位として含むホモポリマー、コポリマー、又はクロスポリマー
That is, this invention provides the leave on skin external preparation for massage characterized by containing the following component (A)-(D).
(A) Liquid ester oil having a viscosity at 25 ° C. of 25 mPa · s or less (B) Linear higher alcohol (C) N-acylamino acid or salt thereof (D) 2-acrylamido-2-methylpropanesulfonic acid or salt thereof , And a homopolymer, copolymer, or crosspolymer containing one or more selected from acrylamide as a structural unit
本発明のマッサージ用リーブオン皮膚外用剤は、安定性に優れ、皮膚上で伸びがよくてマッサージし易く、べたつかず、ぎらつきやヨレが生じず、かつ、保湿感、浸透感に優れたものである。さらに、本発明のマッサージ用リーブオン皮膚外用剤を適用後、すぐにメイクアップも可能で、メイクアップ化粧料の化粧のりを向上させる効果も得られる。 The leave-on skin external preparation for massage of the present invention is excellent in stability, stretches well on the skin, is easy to massage, does not become sticky, does not cause glare or twist, and has excellent moisturizing feeling and penetration feeling. is there. Furthermore, after applying the leave-on skin external preparation for massage of the present invention, makeup can be performed immediately, and the effect of improving the makeup paste of the makeup cosmetic can be obtained.
本発明に用いられる(A)25℃における粘度が25mPa・s以下の液状エステル油は、低粘度の液状エステル油であり、皮膚上での伸びがよく、マッサージがし易く、べたつきのない油剤である。 (A) The liquid ester oil having a viscosity of 25 mPa · s or less at 25 ° C. used in the present invention is a low-viscosity liquid ester oil, which is easy to massage, easy to massage and non-sticky. is there.
(A)成分としては、炭素数6〜24の脂肪酸と炭素数2〜24の1価アルコールとのエステル、炭素数6〜24の脂肪酸とプロピレングリコール、プロパンジオール等の炭素数2〜4の2価アルコールとのモノ又はジ−エステル、炭素数4〜10の2塩基脂肪酸と炭素数2〜8の1価アルコールとのジエステル、炭酸と炭素数6〜18の1価アルコールとのジエステル等が挙げられる。
このうち、炭素数8〜10の脂肪酸と炭素数2〜24の1価アルコールとのエステル、炭酸と炭素数6〜18の1価アルコールとのジエステル、炭素数8〜10の脂肪酸と炭素数2〜4の2価アルコールとのジエステル、炭素数8〜10の2塩基脂肪酸と炭素数2〜4の1価アルコールとのジエステルがより好ましい。ここで脂肪酸及びアルコールは直鎖でも分岐でもよい。
As the component (A), an ester of a fatty acid having 6 to 24 carbon atoms and a monohydric alcohol having 2 to 24 carbon atoms, 2 having 2 to 4 carbon atoms such as a fatty acid having 6 to 24 carbon atoms, propylene glycol, propanediol and the like. Mono- or di-ester with a monohydric alcohol, diester of a dibasic fatty acid having 4 to 10 carbon atoms with a monohydric alcohol with 2 to 8 carbon atoms, diester with carbonic acid and a monohydric alcohol with 6 to 18 carbon atoms, etc. It is done.
Among these, esters of fatty acids having 8 to 10 carbon atoms and monohydric alcohols having 2 to 24 carbon atoms, diesters of carbonic acid and monohydric alcohols having 6 to 18 carbon atoms, fatty acids having 8 to 10 carbon atoms and carbon numbers 2 Diesters with -4 dihydric alcohols, diesters with dibasic fatty acids having 8 to 10 carbon atoms and monohydric alcohols having 2 to 4 carbon atoms are more preferred. Here, the fatty acid and alcohol may be linear or branched.
当該(A)成分の具体例としては、ミリスチン酸イソプロピル、ミリスチン酸ブチル、パルミチン酸イソプロピル、オレイン酸エチル、リノール酸エチル、リノール酸イソプロピル、カプリル酸セチル、ラウリン酸ヘキシル、ミリスチン酸デシル、オレイン酸デシル、オレイン酸オレイル、イソノナン酸イソトリデシル、ミリスチン酸イソセチル、パルミチン酸イソセチル、パルミチン酸エチルヘキシル、ジオレイン酸プロピレングリコール、イソステアリン酸イソプロピル、2−エチルヘキサン酸セチル、ジ(カプリル酸/カプリン酸)プロパンジオール、ジカプリン酸プロピレングリコール、ジオレイン酸プロピレングリコール、イソノナン酸イソノニル、セバシン酸ジイソプロピル、イソステアリン酸プロピレングリコール、炭酸ジカプリリル等を挙げることが出来る。これらは、1種又は2種以上を適宜組み合わせて用いることができる。 Specific examples of the component (A) include isopropyl myristate, butyl myristate, isopropyl palmitate, ethyl oleate, ethyl linoleate, isopropyl linoleate, cetyl caprylate, hexyl laurate, decyl myristate, decyl oleate Oleyl oleate, isotridecyl isononanoate, isocetyl myristate, isocetyl palmitate, ethylhexyl palmitate, propylene glycol dioleate, isopropyl isostearate, cetyl 2-ethylhexanoate, di (caprylic acid / capric acid) propanediol, dicapric acid Propylene glycol, propylene glycol dioleate, isononyl isononanoate, diisopropyl sebacate, propylene glycol isostearate, dica carbonate Ririru, etc. can be mentioned. These can be used alone or in combination of two or more.
本発明では皮膚用外用剤中に、べたつき感を抑え、マッサージ時の使用感の向上の点から、さらに(A)成分は、25℃における粘度が15mPa・s以下のエステル油であることが好ましく、より好ましくは3mPa・s以上、15mPa・s以下であることがより好ましい。なお、粘度測定は、1気圧下、25℃でB型粘度計(ビスメトロン粘度計:型式VS−A1(芝浦システム製);ローターNo.1、60回転/分、30秒)で行うことができる。 In the present invention, it is preferable that the component (A) is an ester oil having a viscosity at 25 ° C. of 15 mPa · s or less from the viewpoint of suppressing the stickiness in the external preparation for skin and improving the feeling of use during massage. More preferably, it is 3 mPa · s or more and 15 mPa · s or less. The viscosity can be measured with a B-type viscometer (Bismetron viscometer: model VS-A1 (manufactured by Shibaura System); rotor No. 1, 60 revolutions / minute, 30 seconds) at 25 ° C. under 1 atm. .
(A)成分のうち、粘度が15mPa・s以下のエステル油として、例えば、イソノナン酸イソノニル、セバシン酸ジイソプロピル、ジ(カプリル酸/カプリン酸)プロパンジオール、2−エチルヘキサン酸セチル、炭酸ジカプリリルなどが好適に挙げられる。これらは1種又は2種以上を組み合わせて使用される。 Among the component (A), as ester oil having a viscosity of 15 mPa · s or less, for example, isononyl isononanoate, diisopropyl sebacate, di (caprylic / capric) propanediol, cetyl 2-ethylhexanoate, dicaprylyl carbonate, etc. Preferably mentioned. These are used alone or in combination of two or more.
本発明で用いる(A)成分は、公知の物質であり、例えばカプリル酸/カプリン酸とプロパンジオールのエステル化により容易に製造できる。また、一般に市販もされており、ジ(カプリル酸/カプリン酸)プロパンジオールとして、日清オイリオグループ株式会社より販売されているサラコスPR−85等が挙げることができる。 (A) component used by this invention is a well-known substance, for example, it can manufacture easily by esterification of caprylic acid / capric acid and propanediol. Moreover, generally also commercially available, as di (caprylic acid / capric acid) propanediol, Saracos PR-85 sold by Nisshin Oilio Group Co., Ltd. can be mentioned.
(A)成分の皮膚外用剤総量に対する含有量は、べたつき感を抑え、かつ、マッサージ可能で、その後、メイクアップが可能な点から、1質量%以上が好ましく、3質量%以上がより好ましく、5質量%以上がさらに好ましく、また20質量%以下が好ましく、18質量%以下がより好ましく、さらに16質量%以下が好ましい。具体的には、1〜20質量%が好ましく、3〜18質量%がより好ましく、5〜16質量%がさらに好ましい。 The content of the component (A) with respect to the total amount of the external preparation for skin is preferably 1% by mass or more, more preferably 3% by mass or more from the viewpoint of suppressing stickiness and being massageable and capable of makeup thereafter. 5 mass% or more is more preferable, 20 mass% or less is preferable, 18 mass% or less is more preferable, and also 16 mass% or less is preferable. Specifically, 1-20 mass% is preferable, 3-18 mass% is more preferable, and 5-16 mass% is further more preferable.
本発明で用いられる(B)直鎖の高級アルコールは、皮膚外用剤に用いられるものであれば特に限定されるものではなく、式ROH(Rは炭素数12以上の直鎖のアルキル又はアルケニル基)で表される炭素数12以上の直鎖のアルコールが好ましく用いられる。高級アルコールは、乳化製剤の安定性の向上、乳化製剤の外観、粘度ならびに塗布する際の延展性、肌おさまり、保湿効果の点から、炭素数12〜24の飽和の直鎖アルコールがより好ましく、炭素数14〜24の飽和直鎖アルコールがさらに好ましく、炭素数16〜22の飽和直鎖アルコールがさらに好ましい。具体的には、ミリスチルアルコール、セチルアルコール、セトステアリルアルコール、ステアリルアルコール、アラキルアルコール、ベヘニルアルコール、カルナービルアルコール等が挙げられ、1種又は2種以上を適宜組み合わせて用いることができる。
これらのうち、好ましくはベヘニルアルコール、ステアリルアルコール、セトステアリルアルコールである。
The (B) linear higher alcohol used in the present invention is not particularly limited as long as it is used for an external preparation for skin. ROH (R is a linear alkyl or alkenyl group having 12 or more carbon atoms) A straight-chain alcohol having 12 or more carbon atoms represented by) is preferably used. The higher alcohol is more preferably a saturated linear alcohol having 12 to 24 carbon atoms from the viewpoint of improving the stability of the emulsion preparation, the appearance of the emulsion preparation, the viscosity and the spreadability at the time of application, the softening of the skin, and the moisturizing effect. A saturated linear alcohol having 14 to 24 carbon atoms is more preferable, and a saturated linear alcohol having 16 to 22 carbon atoms is more preferable. Specific examples include myristyl alcohol, cetyl alcohol, cetostearyl alcohol, stearyl alcohol, aralkyl alcohol, behenyl alcohol, carnervir alcohol, and the like, and one or more can be used in appropriate combination.
Of these, behenyl alcohol, stearyl alcohol, and cetostearyl alcohol are preferable.
(B)成分の皮膚外用剤総量に対する含有量は、べたつき感を抑え、かつ、マッサージ可能で、その後、メイクアップが可能な点から、0.1質量%以上が好ましく、0.3質量%以上がより好ましく、0.5質量%以上がさらに好ましく、また8質量%以下が好ましく、6質量%以下がより好ましく、さらに4質量%以下が好ましい。具体的には、0.1〜8質量%が好ましく、0.3〜6質量%がより好ましく、0.5〜4質量%がさらに好ましい。 The content of the component (B) with respect to the total amount of the external preparation for skin is preferably 0.1% by mass or more, preferably 0.3% by mass or more from the viewpoint of suppressing stickiness and being massageable and capable of making up thereafter. Is more preferable, 0.5 mass% or more is further preferable, 8 mass% or less is preferable, 6 mass% or less is more preferable, and further 4 mass% or less is preferable. Specifically, 0.1-8 mass% is preferable, 0.3-6 mass% is more preferable, and 0.5-4 mass% is further more preferable.
本発明で用いられる(C)N−アシルアミノ酸又はその塩は、水溶性の界面活性剤である。N−アシルアミノ酸を構成するアミノ酸としては、グルタミン酸、アスパラギン酸、グリシン、アラニン、スレオニン、メチルアラニン、サルコシン、リジン、アルギニン等が挙げられる。これらのアミノ酸は、L体、D体又はDL体の何れでもよい。これらのうち1種類を使用してもよいし、上記の群から選ばれる2種以上を混合して使用してもよい。分散安定性、べたつき感のなさの点から、酸性アミノ酸又は中性アミノ酸がより好ましい。具体的には、グルタミン酸、アスパラギン酸、グリシン、アラニンが更に好ましく、グルタミン酸が特に好ましい。また、N−アシルアミノ酸の塩としては、ナトリウム塩、カリウム塩などのアルカリ金属塩、アンモニウム塩、エタノールアミン塩等のアミン塩が挙げられる。 The (C) N-acylamino acid or salt thereof used in the present invention is a water-soluble surfactant. Examples of amino acids constituting the N-acyl amino acid include glutamic acid, aspartic acid, glycine, alanine, threonine, methylalanine, sarcosine, lysine, arginine and the like. These amino acids may be L-form, D-form or DL-form. One of these may be used, or two or more selected from the above group may be mixed and used. From the viewpoints of dispersion stability and no stickiness, acidic amino acids or neutral amino acids are more preferred. Specifically, glutamic acid, aspartic acid, glycine, and alanine are more preferable, and glutamic acid is particularly preferable. Examples of N-acyl amino acid salts include alkali metal salts such as sodium salts and potassium salts, and amine salts such as ammonium salts and ethanolamine salts.
(C)成分の皮膚外用剤総量に対する含有量は、べたつき感を抑え、かつ安定性を保持する点から、0.1質量%以上が好ましく、0.3質量%以上がより好ましく、0.5質量%以上がさらに好ましく、また2質量%以下が好ましく、1.8質量%以下がより好ましく、さらに1.6質量%以下が好ましい。具体的には、0.1〜2質量%が好ましく、0.3〜1.8質量%がより好ましく、0.5〜1.6質量%がさらに好ましい。 The content of the component (C) with respect to the total amount of the external preparation for skin is preferably 0.1% by mass or more, more preferably 0.3% by mass or more, from the viewpoint of suppressing stickiness and maintaining stability. % By mass or more is more preferable, 2% by mass or less is preferable, 1.8% by mass or less is more preferable, and 1.6% by mass or less is more preferable. Specifically, 0.1 to 2 mass% is preferable, 0.3 to 1.8 mass% is more preferable, and 0.5 to 1.6 mass% is more preferable.
本発明で用いられる(D)2−アクリルアミド−2−メチルプロパンスルホン酸及びアクリルアミドから選ばれる1種又は2種以上を構成単位として含むホモポリマー、コポリマー、又はクロスポリマーは特に限定されるものではない。具体的にはビニルピロリドン/2−アクリルアミド−2−メチルプロパンスルホン酸(塩)共重合体、ジメチルアクリルアミド/2−アクリルアミド−2−メチルプロパンスルホン酸(塩)共重合体、アクリルアミド/2−アクリルアミド−2−メチルプロパンスルホン酸共重合体、メチレンビスアクリルアミドでクロスリンクさせたジメチルアクリルアミド/2−アクリルアミド−2−メチルプロパンスルホン酸のクロスポリマー、ポリアクリルアミドとポリアクリル酸ナトリウムの混合物、アクリル酸ナトリウム/2−アクリルアミド−2−メチルプロパンスルホン酸共重合体、アクリル酸ヒドロキシエチル/2−アクリルアミド−2−メチルプロパンスルホン酸(塩)共重合体、ポリアクリルアミド/アクリル酸アンモニウム共重合体、アクリルアミド/アクリル酸ナトリウム共重合体等が挙げられる。ただし、これらの例示に限定されるものではない。
上記において、塩としては、アルカリ金属塩(例えば、カルシウム塩、マグネシウム塩等)、アンモニウム塩、有機アミン類塩(例えば、モノエタノールアミン塩、ジエタノールアミン塩、トリエタノールアミン塩、トリエタノールアミン塩等)などが好適例として挙げられる。これらの(D)成分は、1種または2種以上を用いることができる。
The homopolymer, copolymer, or crosspolymer containing (D) 2-acrylamido-2-methylpropanesulfonic acid and acrylamide selected from (D) as a constituent unit in the present invention is not particularly limited. . Specifically, vinylpyrrolidone / 2-acrylamido-2-methylpropanesulfonic acid (salt) copolymer, dimethylacrylamide / 2-acrylamido-2-methylpropanesulfonic acid (salt) copolymer, acrylamide / 2-acrylamide- 2-methylpropanesulfonic acid copolymer, dimethylacrylamide / 2-acrylamide-2-methylpropanesulfonic acid cross-polymer cross-linked with methylenebisacrylamide, mixture of polyacrylamide and sodium polyacrylate, sodium acrylate / 2 Acrylamide-2-methylpropanesulfonic acid copolymer, hydroxyethyl acrylate / 2-acrylamido-2-methylpropanesulfonic acid (salt) copolymer, polyacrylamide / ammonium acrylate copolymer Acrylamide / sodium acrylate copolymer and the like. However, it is not limited to these examples.
In the above, as the salt, alkali metal salt (for example, calcium salt, magnesium salt, etc.), ammonium salt, organic amine salt (for example, monoethanolamine salt, diethanolamine salt, triethanolamine salt, triethanolamine salt, etc.) And the like. 1 type, or 2 or more types can be used for these (D) components.
これらの(D)成分は、合成したものでも市販品でもよい。例えば、ビニルピロリドン/2−アクリルアミド−2−メチルプロパンスルホン酸(塩)共重合体としては、「ARISTOFLEX AVC」(Clariant社製)、アクリル酸ナトリウム/2−アクリルアミド−2−メチルプロパンスルホン酸(塩)共重合体としては、「SIMULGEL EG」(SPPIC社製)、「SIMULGEL EPG」(SPPIC社製)、アクリルアミド/2−アクリルアミド−2−メチルプロパンスルホン酸ナトリウム塩共重合体としては、「SIMULGEL 600」(SEPPIC社製)、アクリルアミド/2−アクリルアミド−2−メチルプロパンスルホン酸(塩)としては、「SEPIGEL 305」(SPPIC社製)、「SEPIGEL 501」(SPPIC社製)、2−アクリルアミド−2−メチルプロパンスルホン酸ナトリウム塩のホモポリマーとしては、「Hostacerin AMPS」(Clariant社製)、「SIMULGEL 800」(SPPIC社製)等が挙げられ、ジメチルアクリルアミド/2−アクリルアミド−2−メチルプロパンスルホン酸としては、「SU−POLYMER G−1」(東邦化学工業(株)社製)等が挙げられる。 These components (D) may be synthesized or commercially available. For example, as vinylpyrrolidone / 2-acrylamido-2-methylpropanesulfonic acid (salt) copolymer, “ARITOFLEX AVC” (manufactured by Clariant), sodium acrylate / 2-acrylamido-2-methylpropanesulfonic acid (salt) ) As the copolymer, “SIMULGEL EG” (manufactured by SPPIC), “SIMULGEL EPG” (manufactured by SPPIC), and acrylamide / 2-acrylamido-2-methylpropanesulfonic acid sodium salt copolymer as “SIMULGEL 600” ”(Made by SEPPIC), acrylamide / 2-acrylamido-2-methylpropanesulfonic acid (salt),“ SEPIGEL 305 ”(made by SPPIC),“ SEPIGEL 501 ”(made by SPPIC), 2-acrylic Examples of homopolymers of amido-2-methylpropanesulfonic acid sodium salt include “Hostacerin AMPS” (manufactured by Clariant), “SIMULGEL 800” (manufactured by SPPIC), and the like. Dimethylacrylamide / 2-acrylamido-2-methyl Examples of propanesulfonic acid include “SU-POLYMER G-1” (manufactured by Toho Chemical Co., Ltd.).
(D)成分の皮膚外用剤総量に対する含有量は、べたつき感を抑え、メイクアップのときにヨレが生じず、かつ安定性を保持する点から、0.1質量%以上が好ましく、0.2質量%以上がより好ましく、0.3質量%以上がさらに好ましく、また2.5質量%以下が好ましく、2.0質量%以下がより好ましく、さらに1.5質量%以下が好ましい。具体的には、0.1〜2.5質量%が好ましく、0.2〜2.0質量%がより好ましく、0.3〜1.5質量%がさらに好ましい。 The content of the component (D) with respect to the total amount of the external preparation for skin is preferably 0.1% by mass or more from the viewpoint of suppressing stickiness, causing no twisting at the time of makeup, and maintaining stability. It is more preferably at least mass%, more preferably at least 0.3 mass%, more preferably at most 2.5 mass%, more preferably at most 2.0 mass%, further preferably at most 1.5 mass%. Specifically, 0.1 to 2.5 mass% is preferable, 0.2 to 2.0 mass% is more preferable, and 0.3 to 1.5 mass% is more preferable.
本発明の皮膚外用剤の剤形としては、特に限定されるものではないが、クリーム、乳液、美容液、サンスクリーンなどに適用が可能であり、さらにスプレー剤、ムース剤としても適用できる。 The dosage form of the external preparation for skin of the present invention is not particularly limited, but can be applied to creams, emulsions, cosmetics, sunscreens, and the like, and can also be applied as sprays and mousses.
本発明の皮膚外用剤は乳化組成物であるのが好ましく、その乳化型としては、油中水型乳化、水中油型乳化等の制限なく、様々な乳化型に応用できるが、べたつき感を抑え、メイクアップがしやすい水中油型乳化組成物とするのが好ましい。 The external preparation for skin of the present invention is preferably an emulsified composition, and the emulsified type can be applied to various emulsified types without limitation of water-in-oil emulsification, oil-in-water emulsification, etc., but suppresses stickiness. An oil-in-water emulsion composition that is easy to make up is preferable.
本発明の皮膚外用剤は、前記の必須成分に加えて必要に応じて本発明の効果を損なわない範囲で通常、医薬品、医薬部外品、化粧料等に使用されている他の任意の成分、例えば、(C)成分以外のアニオン性界面活性剤、カチオン性界面活性剤、非イオン性界面活性剤、(A)成分以外の油分、紫外線吸収剤、防腐剤、保湿剤、(D)成分以外のポリマー類、アミノ酸誘導体、糖誘導体、香料、水、アルコール、増粘剤、色剤、金属イオン封鎖剤、酸化防止剤、薬剤等の成分を適宜配合することができる。 The external preparation for skin of the present invention is, in addition to the essential components described above, other optional components that are usually used in pharmaceuticals, quasi-drugs, cosmetics and the like as long as the effects of the present invention are not impaired as necessary. For example, anionic surfactants other than component (C), cationic surfactants, nonionic surfactants, oils other than component (A), ultraviolet absorbers, preservatives, humectants, component (D) Other components such as polymers, amino acid derivatives, sugar derivatives, fragrances, water, alcohols, thickeners, colorants, sequestering agents, antioxidants, and drugs can be appropriately blended.
本発明の皮膚外用剤は、顔、手、足等の皮膚に塗布し、マッサージすることにより使用されるマッサージ用皮膚外用剤である。また、マッサージ終了後、洗い流す必要はなく、リーブオンタイプの皮膚外用剤である。本発明の皮膚外用剤を用いてマッサージ後、メイクアップをすることも可能である。 The external preparation for skin of the present invention is an external preparation for massage used by applying to the skin of the face, hands, feet, etc. and massaging. In addition, it is a leave-on type skin external preparation that does not need to be washed away after the massage is completed. It is also possible to make up after massage using the external preparation for skin of the present invention.
上述の実施形態に関し、本発明はさらに以下の実施態様を開示する。 In relation to the above-described embodiment, the present invention further discloses the following embodiment.
<1>下記成分(A)〜(D)を含有することを特徴とするマッサージ用リーブオン皮膚外用剤。
(A)25℃における粘度が25mPa・s以下の液状エステル油
(B)直鎖の高級アルコール
(C)N−アシルアミノ酸又はその塩
(D)2−アクリルアミド−2−メチルプロパンスルホン酸又はその塩、及びアクリルアミドから選ばれる1種又は2種以上を構成単位として含むホモポリマー、コポリマー、又はクロスポリマー
<1> A leave-on skin external preparation for massage, comprising the following components (A) to (D).
(A) Liquid ester oil having a viscosity at 25 ° C. of 25 mPa · s or less (B) Linear higher alcohol (C) N-acylamino acid or salt thereof (D) 2-acrylamido-2-methylpropanesulfonic acid or salt thereof , And a homopolymer, copolymer, or crosspolymer containing one or more selected from acrylamide as a structural unit
<2>(A)成分が、炭素数6〜24の脂肪酸と炭素数2〜24の1価アルコールとのエステル、炭素数6〜24の脂肪酸とプロピレングリコール、プロパンジオール等の炭素数2〜4の2価アルコールとのモノ又はジ−エステル、炭素数4〜10の2塩基脂肪酸と炭素数2〜8の1価アルコールとのジエステル及び炭酸と炭素数6〜18の1価アルコールとのジエステルから選ばれる1種又は2種以上である<1>の皮膚外用剤。
<3>(A)成分が、炭素数8〜10の脂肪酸と炭素数2〜24の1価アルコールとのエステル、炭酸と炭素数6〜18の1価アルコールとのジエステル、炭素数8〜10の脂肪酸と炭素数2〜4の2価アルコールとのジエステル、及び炭素数8〜10の2塩基脂肪酸と炭素数2〜4の1価アルコールとのジエステルから選ばれる1種又は2種以上である<1>又は<2>の皮膚外用剤。
<4>(A)成分が、25℃における粘度が15mPa・s以下のエステル油である<1>〜<3>のいずれかの皮膚外用剤。
<5>(A)成分の皮膚外用剤総量に対する含有量が、好ましくは1質量%以上、より好ましくは3質量%以上、さらに好ましくは5質量%以上であり、また好ましくは20質量%以下、より好ましくは18質量%以下、さらに好ましくは16質量%以下である<1>〜<4>のいずれかの皮膚外用剤。
<6>(A)成分の皮膚外用剤総量に対する含有量が、好ましくは1〜20質量%、より好ましくは3〜18質量%、さらに好ましくは5〜16質量%である<1>〜<5>のいずれかの皮膚外用剤。
<7>(B)成分が、好ましくは炭素数12以上の直鎖アルコール、より好ましくは炭素数12〜24の飽和の直鎖アルコール、さらに好ましくは炭素数14〜24の飽和直鎖アルコール、さらに好ましくは炭素数16〜22の飽和直鎖アルコール、さらに好ましくはミリスチルアルコール、セチルアルコール、セトステアリルアルコール、ステアリルアルコール、アラキルアルコール、ベヘニルアルコール及びカルナービルアルコールから選ばれる1種又は2種以上である<1>〜<6>のいずれかの皮膚外用剤。
<8>(B)成分の皮膚外用剤総量に対する含有量が、好ましくは0.1質量%以上、より好ましくは0.3質量%以上、さらに好ましくは0.5質量%以上であり、また好ましくは8質量%以下、より好ましくは6質量%以下、さらに好ましくは4質量%以下である<1>〜<7>のいずれかの皮膚外用剤。
<9>(B)成分の皮膚外用剤総量に対する含有量が、好ましくは0.1〜8質量%、より好ましくは0.3〜6質量%、さらに好ましくは0.5〜4質量%である<1>〜<8>のいずれかの皮膚外用剤。
<10>(C)成分のN−アシルアミノ酸を構成するアミノ酸が、グルタミン酸、アスパラギン酸、グリシン、アラニン、スレオニン、メチルアラニン、サルコシン、リジン及びアルギニンから選ばれる1種又は2種以上である<1>〜<9>のいずれかの皮膚外用剤。
<11>(C)成分の皮膚外用剤総量に対する含有量が、好ましくは0.1質量%以上、より好ましくは0.3質量%以上、さらに好ましくは0.5質量%以上であり、また好ましくは2質量%以下、より好ましくは1.8質量%以下、さらに好ましくは1.6質量%以下である<1>〜<10>のいずれかの皮膚外用剤。
<12>(C)成分の皮膚外用剤総量に対する含有量が、好ましくは0.1〜2質量%、より好ましくは0.3〜1.8質量%、さらに好ましくは0.5〜1.6質量%である<1>〜<11>のいずれかの皮膚外用剤。
<13>(D)成分が、ビニルピロリドン/2−アクリルアミド−2−メチルプロパンスルホン酸(塩)共重合体、ジメチルアクリルアミド/2−アクリルアミド−2−メチルプロパンスルホン酸(塩)共重合体、アクリルアミド/2−アクリルアミド−2−メチルプロパンスルホン酸共重合体、メチレンビスアクリルアミドでクロスリンクさせたジメチルアクリルアミド/2−アクリルアミド−2−メチルプロパンスルホン酸のクロスポリマー、ポリアクリルアミドとポリアクリル酸ナトリウムの混合物、アクリル酸ナトリウム/2−アクリルアミド−2−メチルプロパンスルホン酸共重合体、アクリル酸ヒドロキシエチル/2−アクリルアミド−2−メチルプロパンスルホン酸(塩)共重合体、ポリアクリルアミド/アクリル酸アンモニウム共重合体、アクリルアミド/アクリル酸ナトリウム共重合体から選ばれる1種又は2種以上であり、より好ましくは、ビニルピロリドン/2−アクリルアミド−2−メチルプロパンスルホン酸(塩)共重合体、ジメチルアクリルアミド/2−アクリルアミド−2−メチルプロパンスルホン酸(塩)共重合体、アクリルアミド/アクリル酸/2−アクリルアミド−2−メチルプロパンスルホン酸(塩)共重合体、ポリアクリルアミドとポリアクリル酸(塩)の混合物、アクリル酸ナトリウム/2−アクリルアミド−2−メチルプロパンスルホン酸(塩)共重合体、アクリルアミド/アクリル酸(塩)共重合体、2−アクリルアミド−2−メチルプロパンスルホン酸(塩)のホモポリマー及びビニルホルムアミド/2−アクリルアミド−2−メチルプロパンスルホン酸(塩)共重合体から選ばれる1種または2種以上である<1>〜<12>のいずれかの皮膚外用剤。
<14>(D)成分の皮膚外用剤総量に対する含有量が、好ましくは0.1質量%以上、より好ましくは0.2質量%以上、さらに好ましくは0.3質量%以上であり、また好ましくは2.5質量%以下、より好ましくは2.0質量%以下、さらに好ましくは1.5質量%以下である<1>〜<13>のいずれかの皮膚外用剤。
<15>(D)成分の皮膚外用剤総量に対する含有量が、好ましくは0.1〜2.5質量%、より好ましくは0.2〜2.0質量%、さらに好ましくは0.3〜1.5質量%である<1>〜<14>のいずれかの皮膚外用剤。
<16>水中油型乳化組成物である<1>〜<15>のいずれかの皮膚外用剤。
<2> The component (A) is an ester of a fatty acid having 6 to 24 carbon atoms and a monohydric alcohol having 2 to 24 carbon atoms, a fatty acid having 6 to 24 carbon atoms, propylene glycol, propanediol, etc. Mono- or di-ester with dihydric alcohol, diester with dibasic fatty acid having 4 to 10 carbon atoms and monohydric alcohol with 2 to 8 carbon atoms, and diester with carbonic acid and monohydric alcohol with 6 to 18 carbon atoms The skin external preparation of <1> which is one or more selected.
<3> Component (A) is an ester of a fatty acid having 8 to 10 carbon atoms and a monohydric alcohol having 2 to 24 carbon atoms, a diester of carbonic acid and a monohydric alcohol having 6 to 18 carbon atoms, or 8 to 10 carbon atoms. It is 1 type, or 2 or more types chosen from the diester of a C2-C4 dihydric alcohol, and the diester of a C8-C10 dibasic fatty acid and a C2-C4 monohydric alcohol <1> or <2> skin external preparation.
The skin external preparation in any one of <1>-<3> whose <4> (A) component is ester oil whose viscosity in 25 degreeC is 15 mPa * s or less.
<5> The content of the component (A) with respect to the total amount of the external preparation for skin is preferably 1% by mass or more, more preferably 3% by mass or more, further preferably 5% by mass or more, and preferably 20% by mass or less. More preferably, it is 18 mass% or less, More preferably, it is 16 mass% or less The skin external preparation in any one of <1>-<4>.
The content of the <6> component (A) with respect to the total amount of the external preparation for skin is preferably 1 to 20% by mass, more preferably 3 to 18% by mass, and further preferably 5 to 16% by mass. > Any one of the external preparations for skin.
<7> Component (B) is preferably a linear alcohol having 12 or more carbon atoms, more preferably a saturated linear alcohol having 12 to 24 carbon atoms, still more preferably a saturated linear alcohol having 14 to 24 carbon atoms, Preferably, it is a saturated linear alcohol having 16 to 22 carbon atoms, more preferably one or more selected from myristyl alcohol, cetyl alcohol, cetostearyl alcohol, stearyl alcohol, aralkyl alcohol, behenyl alcohol and carnervir alcohol < The skin external preparation in any one of 1>-<6>.
<8> The content of the component (B) with respect to the total amount of the external preparation for skin is preferably 0.1% by mass or more, more preferably 0.3% by mass or more, and further preferably 0.5% by mass or more. Is 8% by mass or less, more preferably 6% by mass or less, and still more preferably 4% by mass or less, according to any one of <1> to <7>.
<9> The content of the component (B) with respect to the total amount of the external preparation for skin is preferably 0.1 to 8% by mass, more preferably 0.3 to 6% by mass, and further preferably 0.5 to 4% by mass. The skin external preparation in any one of <1>-<8>.
<10> The amino acid constituting the N-acylamino acid of component (C) is one or more selected from glutamic acid, aspartic acid, glycine, alanine, threonine, methylalanine, sarcosine, lysine and arginine <1 The skin external preparation according to any one of> to <9>.
<11> The content of the component (C) with respect to the total amount of the external preparation for skin is preferably 0.1% by mass or more, more preferably 0.3% by mass or more, further preferably 0.5% by mass or more, and preferably Is 2% by mass or less, more preferably 1.8% by mass or less, and still more preferably 1.6% by mass or less, according to any one of <1> to <10>.
<12> The content of the component (C) with respect to the total amount of the external preparation for skin is preferably 0.1 to 2% by mass, more preferably 0.3 to 1.8% by mass, and further preferably 0.5 to 1.6%. The skin external preparation according to any one of <1> to <11>, which is% by mass.
<13> (D) component is vinylpyrrolidone / 2-acrylamido-2-methylpropanesulfonic acid (salt) copolymer, dimethylacrylamide / 2-acrylamido-2-methylpropanesulfonic acid (salt) copolymer, acrylamide / 2-acrylamido-2-methylpropanesulfonic acid copolymer, dimethylacrylamide / 2-acrylamido-2-methylpropanesulfonic acid cross-polymer cross-linked with methylenebisacrylamide, a mixture of polyacrylamide and sodium polyacrylate, Sodium acrylate / 2-acrylamido-2-methylpropanesulfonic acid copolymer, hydroxyethyl acrylate / 2-acrylamido-2-methylpropanesulfonic acid (salt) copolymer, polyacrylamide / ammonium acrylate One or two or more types selected from a copolymer and an acrylamide / sodium acrylate copolymer, more preferably a vinylpyrrolidone / 2-acrylamide-2-methylpropanesulfonic acid (salt) copolymer, dimethylacrylamide / 2-acrylamido-2-methylpropanesulfonic acid (salt) copolymer, acrylamide / acrylic acid / 2-acrylamido-2-methylpropanesulfonic acid (salt) copolymer, polyacrylamide and polyacrylic acid (salt) Mixture, sodium acrylate / 2-acrylamido-2-methylpropanesulfonic acid (salt) copolymer, acrylamide / acrylic acid (salt) copolymer, homopolymer of 2-acrylamido-2-methylpropanesulfonic acid (salt) And vinylformamide / 2-acrylamide-2-methyl The skin external preparation according to any one of <1> to <12>, which is one or more selected from a rupropanesulfonic acid (salt) copolymer.
<14> The content of the component (D) with respect to the total amount of the external preparation for skin is preferably 0.1% by mass or more, more preferably 0.2% by mass or more, and still more preferably 0.3% by mass or more. Is 2.5% by mass or less, more preferably 2.0% by mass or less, and still more preferably 1.5% by mass or less, according to any one of <1> to <13>.
<15> The content of the component (D) with respect to the total amount of the external preparation for skin is preferably 0.1 to 2.5% by mass, more preferably 0.2 to 2.0% by mass, and further preferably 0.3 to 1%. The external preparation for skin according to any one of <1> to <14>, which is 5% by mass.
<16> The external preparation for skin according to any one of <1> to <15>, which is an oil-in-water emulsion composition.
以下、実施例、比較例により詳細に説明する。尚、組成の単位は全て質量%である。 Hereinafter, it demonstrates in detail by an Example and a comparative example. In addition, the unit of a composition is all the mass%.
実施例に先立ち、実施例において行った(1)保存安定性試験、(2)官能評価試験について説明する。 Prior to the examples, (1) storage stability test and (2) sensory evaluation test performed in the examples will be described.
(保存安定性試験)
試料をガラスビンに入れ、45℃で3ヶ月放置後の状態、外観を観察し、異常が認められる場合(分離、析出等)を×で表し、異常が認められない場合を○で表した。
(Storage stability test)
The sample was placed in a glass bottle, and the state and appearance after being left at 45 ° C. for 3 months were observed. When an abnormality was observed (separation, precipitation, etc.), x was indicated, and when no abnormality was observed, it was indicated by ○.
(官能評価試験)
専門女性パネル(10名)につき、実施例に示す皮膚用乳化組成物を使用して、「マッサージのしやすさ」、「保湿感」、「べたつき」、「肌残り感(ぎらつき、ヨレ)」の5項目に関してアンケートを行い、下記の評価基準に基づき、評価を行った。結果はその評価の平均点で示す。
(Sensory evaluation test)
Using the emulsified composition for skin shown in the examples for 10 professional female panels, "Easy to massage", "Moisturizing feeling", "Sticky", "Skin feel (glitter, twist) The questionnaire was conducted on the five items, and the evaluation was performed based on the following evaluation criteria. A result is shown by the average score of the evaluation.
(評価基準)
マッサージのしやすさ
5:良い
4:やや良い
3:どちらともいえない
2:やや悪い
1:悪い
(Evaluation criteria)
Ease of massage 5: Good 4: Slightly good 3: Not good 2: Slightly bad 1: Bad
保湿感
5:良い
4:やや良い
3:どちらともいえない
2:やや悪い
1:悪い
Moisturizing sensation 5: Good 4: Slightly good 3: Neither can be said 2: Slightly bad 1: Bad
べたつきのなさ
5:無い
4:やや無い
3:どちらともいえない
2:やや有る
1:有る
No stickiness 5: None 4: Slightly absent 3: Neither can be said 2: Slightly present 1: Present
肌残り感(ぎらつき、ヨレ)
5:無い
4:やや無い
3:どちらともいえない
2:やや有る
1:有る
Feeling of remaining skin (glare, twist)
5: None 4: Slightly absent 3: Neither can be said 2: Slightly present 1: Present
実施例1〜8、比較例1〜6
表1及び表2に記載の組成で示した皮膚用乳化組成物を常法により作製し、前記の試験を実施した。結果を表1及び表2に併せて示す。
Examples 1-8, Comparative Examples 1-6
Skin emulsified compositions having the compositions described in Tables 1 and 2 were prepared by a conventional method, and the above test was performed. The results are shown in Table 1 and Table 2 together.
表1及び表2より明らかなように、本発明の(A)〜(D)成分を含有するマッサージ用リーブオン皮膚用乳化組成物は、長期間安定で、皮膚上での伸びが良くマッサージし易く、保湿感に優れ、べたつきがなく、かつ肌残り感(ざらつき、ヨレ)がないものであった。また、塗布後にメイクアップを行っても、化粧のりが良好であった。
一方、(A)成分を配合しない又は(A)成分に該当しない液状油を配合した場合(比較例1〜3)は、マッサージのしやすさ、保湿感、べたつきのなさ、肌残り感等の点で劣っていた。また、(B)成分、(C)成分又は(D)成分を配合しなかった場合(比較例4〜6)は、保存安定性が悪く、また使用感評価も十分でなかった。
As is clear from Tables 1 and 2, the leave-on emulsified composition for massage containing the components (A) to (D) of the present invention is stable for a long period of time, has good elongation on the skin, and is easy to massage. It had excellent moisturizing feeling, no stickiness, and no feeling of skin residue (roughness, twisting). Further, even if makeup was applied after application, the cosmetic paste was good.
On the other hand, when (A) component is not blended or liquid oil that does not correspond to (A) component is blended (Comparative Examples 1 to 3), such as ease of massage, moisturizing feeling, non-stickiness, feeling of remaining skin, etc. It was inferior in respect. Moreover, when (B) component, (C) component, or (D) component was not mix | blended (Comparative Examples 4-6), storage stability was bad and usability evaluation was also not enough.
次に、本発明の皮膚用乳化組成物の処方例を表3及び表4に示す。 Next, Table 3 and Table 4 show formulation examples of the emulsion composition for skin of the present invention.
上記組成の皮膚用乳化組成物(美容液)を常法により調製し、保存安定性、保湿感、のび、べたつきのなさ及びきしみのいずれの面においても優れていた。 An emulsified composition for skin (beauty liquid) having the above composition was prepared by a conventional method, and was excellent in all aspects of storage stability, moisturizing feeling, spread, non-stickiness, and creaking.
上記組成の皮膚用乳化組成物(クリーム)を常法により調製し、保存安定性に優れ、保湿感、マッサージのしやすさ、べたつきのなさ及び肌残り感(ぎらつき、ヨレ)の良さのいずれの面においても優れていた。 An emulsion composition for skin (cream) having the above composition is prepared by a conventional method, and is excellent in storage stability, moisturizing feeling, ease of massage, non-stickiness and good feeling of skin residue (glare, twist) It was also excellent in terms of
Claims (3)
(A)炭酸と炭素数6〜18の1価アルコールとのジエステル、炭素数8〜10の脂肪酸と炭素数2〜4の2価アルコールとのジエステル、及び炭素数8〜10の2塩基脂肪酸と炭素数2〜4の1価アルコールとのジエステルから選ばれる1種又は2種以上を含む、25℃における粘度が15mPa・s以下の液状エステル油:5〜16質量%
(B)直鎖の高級アルコール:1.5〜4質量%
(C)構成アミノ酸がグルタミン酸、アスパラギン酸、グリシン、アラニン、スレオニン、メチルアラニン、サルコシン、リジン及びアルギニンから選ばれる1種又は2種以上であるN−アシルアミノ酸又はその塩:0.1〜2質量%
(D)2−アクリルアミド−2−メチルプロパンスルホン酸又はその塩、及びアクリルアミドから選ばれる1種又は2種以上を構成単位として含むホモポリマー、コポリマー、又はクロスポリマー:0.2〜2.0質量% A leave-on skin external preparation for massage comprising the following components (A) to (D).
(A) a diester of carbonic acid and a monohydric alcohol having 6 to 18 carbon atoms, a diester of a fatty acid having 8 to 10 carbon atoms and a dihydric alcohol having 2 to 4 carbon atoms, and a dibasic fatty acid having 8 to 10 carbon atoms Liquid ester oil having a viscosity at 25 ° C. of 15 mPa · s or less, including one or more selected from diesters with monohydric alcohols having 2 to 4 carbon atoms : 5 to 16% by mass
(B) Linear higher alcohol : 1.5 to 4% by mass
(C) N-acyl amino acid or salt thereof in which the constituent amino acid is one or more selected from glutamic acid, aspartic acid, glycine, alanine, threonine, methylalanine, sarcosine, lysine and arginine : 0.1 to 2 mass %
(D) Homopolymer, copolymer, or crosspolymer containing one or more selected from 2-acrylamido-2-methylpropanesulfonic acid or a salt thereof and acrylamide as a structural unit : 0.2 to 2.0 mass %
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012287628A JP6130142B2 (en) | 2012-12-28 | 2012-12-28 | Topical skin preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012287628A JP6130142B2 (en) | 2012-12-28 | 2012-12-28 | Topical skin preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2014129277A JP2014129277A (en) | 2014-07-10 |
JP6130142B2 true JP6130142B2 (en) | 2017-05-17 |
Family
ID=51408045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012287628A Active JP6130142B2 (en) | 2012-12-28 | 2012-12-28 | Topical skin preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6130142B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2022255271A1 (en) * | 2021-06-04 | 2022-12-08 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2819245B1 (en) * | 2001-01-09 | 2004-11-26 | Clariant | NOVEL AQUEOUS SUSPENSIONS OF NEUTRAL PH ANIONIC COLLOIDAL SILICA AND PREPARATION METHOD THEREOF, AND APPLICATIONS THEREOF |
JP2006117534A (en) * | 2004-10-19 | 2006-05-11 | Kose Corp | Emulsified cosmetic |
JP2008106043A (en) * | 2006-09-29 | 2008-05-08 | Kose Corp | Oil-in-water (o/w) type emulsion cosmetic |
JP2008255023A (en) * | 2007-04-02 | 2008-10-23 | Kao Corp | External preparation for skin |
JP5683865B2 (en) * | 2010-08-10 | 2015-03-11 | 花王株式会社 | Emulsified cosmetics |
US20120156146A1 (en) * | 2010-11-19 | 2012-06-21 | Tomohiro Hakozaki | Compositions and Methods for Improving the Appearance of Facial Texture |
JP2012224623A (en) * | 2011-04-08 | 2012-11-15 | Kao Corp | Oil-in-water type emulsified composition |
-
2012
- 2012-12-28 JP JP2012287628A patent/JP6130142B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2014129277A (en) | 2014-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3912546B2 (en) | Shampoo composition | |
JP6831639B2 (en) | Oil-in-water emulsified composition | |
JP5342736B2 (en) | Oil-in-water emulsion and method for producing the same | |
WO2002041853A1 (en) | O/w emulsion composition and method of preparing the same | |
JP6057461B2 (en) | Alpha gel structure and cosmetic or skin external preparation containing the same | |
JP6118546B2 (en) | Oil-in-water emulsion composition | |
JP5773783B2 (en) | Moisturizing cosmetics | |
BR112013015453B1 (en) | NON-FOAMING COMPOSITION AND METHOD FOR NON-THERAPEUTIC TREATMENT OF KERATIN MATERIALS | |
JP2008106043A (en) | Oil-in-water (o/w) type emulsion cosmetic | |
JP2012240987A (en) | Viscous composition | |
JP2003176211A (en) | Oily thickened gel-like composition, emulsified composition using the same and method for preparing the emulsified composition | |
JP2013018751A (en) | Oil-in-water emulsion cosmetic | |
JP5892720B2 (en) | Skin preparation | |
KR20160065658A (en) | Emulsifier-Free Washable Cleansing Cosmetic Composition | |
JP6130142B2 (en) | Topical skin preparation | |
JP2008266252A (en) | Milky lotion of skin cosmetic | |
JP2015074606A (en) | Leave-on hair cosmetic | |
JP6830735B2 (en) | Emulsified skin external preparation | |
JP5566099B2 (en) | Skin cosmetics | |
JP2024506121A (en) | water-based emulsion | |
JP2003012476A (en) | Semisolid hair cosmetic | |
JP7569233B2 (en) | Hair styling composition | |
US20130065871A1 (en) | Emulsion composition | |
JP7500193B2 (en) | Emulsion composition | |
JP6927833B2 (en) | Oil-in-water skin cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20150930 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20160729 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160802 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160928 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20161101 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20161219 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170228 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20170404 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170413 |
|
R151 | Written notification of patent or utility model registration |
Ref document number: 6130142 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |